Integrated continuous manufacturing (ICM) offers significant advantages over traditional batch pharmaceutical manufacturing. ICM allows for a seamless, integrated process with fewer unit operations and excipients. It can reduce costs by over 50%, lead times to under 2 days, and improve quality. While ICM faces barriers such as regulatory concerns and technological challenges, its benefits could include annual savings of billions of dollars for pharmaceutical companies through reduced costs of goods sold and inventory. ICM is seen as the future of pharmaceutical manufacturing.